Physician profile
Brian Mccarthy
NPI 1174609168
$3,835.11
in general payments reported to CMS, 2019-2025
18 companies · $519 in 2025
The $519 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $562 · 2022: $1,962 · 2023: $423 · 2024: $370 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,311.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,200.00 | 2022 | |
| Getinge USA Sales, LLC | $1,125.82 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2, Cardiohelp |
| Medtronic, INC. | $666.19 | 2021-2023 | Corevalve Evolut R |
| Atricure, INC. | $130.63 | 2022-2024 | |
| Supreme Orthopedic Systems, LLC | $128.57 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $120.15 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $104.86 | 2022-2024 | Hemosphere, Mitris Resilia Mitral Valve |
| Ethicon US, LLC | $72.53 | 2023-2024 | Prolene, Evarrest |
| Stryker Corporation | $53.00 | 2024 | |
| Biocomposites INC | $36.47 | 2024 | |
| Biosense Webster, INC. | $35.49 | 2025 | Carto 3 |
| Baxter Healthcare | $35.23 | 2024 | Coseal |
| Abiomed | $25.32 | 2023 | Impella |
| Merck Sharp & Dohme LLC | $25.10 | 2024 | Keytruda |
| Abbott Laboratories | $23.23 | 2025 | Thoratec Heartmate 3 Lvas Implant Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $20.13 | 2022 | |
| Janssen Biotech, INC. | $16.83 | 2025 | Stelara, Tremfya, Simponi Aria |
| Sanara Medtech INC. | $15.56 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.